Statin use may reduce risk of cataracts

General

Clinical Question:
Do statins reduce the risk of cataracts?

Bottom Line:
Statin use is associated with a reduced incidence of nuclear cataracts, the most common type of age-related cataracts. However, this type of study design (prospective cohort study) does not prove a causal relationship between the use of statins and lower risk of developing cataracts. It is possible that other confounding variables (eg, genetics or patient compliance) are causally related. (LOE = 2b)

Reference:
Klein BE, Klein R, Lee KE, Grady LM. Statin use and incident nuclear cataract. JAMA 2006;295:2752-2758.  [PMID:16788130]

Study Design:
Cohort (prospective)

Funding:
Foundation

Setting:
Population-based

Synopsis:
These investigators analyzed data obtained from an observational, longitudinal study of age-related eye disease in Beaver Dam, Wisconsin. A total of 1299 adults with gradable photographs in both eyes underwent evaluation for nuclear cataracts, the most common type of age-related cataract, 5 years after the start of the study. Almost all (99%) of the population was non-Hispanic white. Individuals assessing outcomes were blinded to participant identity and drug use. The 5-year incidence of nuclear cataract was 12.2% in statin users compared with 17.2% in nonusers (odds ratio = 0.55; 95% CI, 0.36-0.84). The reduced incidence for statin users remained significant after controlling for age, sex, smoking, lipid level, and diabetes. The incidence of other types of cataracts, including cortical and posterior subcapsular, was not significantly reduced.

Statin use may reduce risk of cataracts is a sample topic from the EE+ POEM Archive.

To view other topics, please or .

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. .